Background. Allogeneic stem cell transplantation (allo-SCT) provides a potential cure for high-risk, recurrent, and refractory hematological cancers (HC). However, allo-SCT survivors experience significant treatment-induced exercise intolerance and associated cardiovascular mortality. Purpose. We conducted a randomized controlled trial in HC patients scheduled for allo-SCT to determine if a 4-mo multifaceted activity program could preserve peak oxygen uptake (V̇O2peak) and its determinants. Methods. Sixty-two HC patients scheduled for allo-SCT were randomized to usual care (UC; n=32, 55±15 y, 63% male) or the multifaceted activity program (Activity; n=30, 50±16 y, 60% male). Patients assigned to Activity completed thrice weekly aerobic and resistance exercise for 4-mo and concurrently aimed to reduce sedentary time by 30-min/d via replacement with short (3-min), frequent (hourly), light-intensity activity. Cardiopulmonary exercise testing (CPET) was conducted prior to allo-SCT admission, and 12-wks following discharge to assess V̇O2peak, as well as peak power output (PPO), respiratory exchange ratio (RER), and heart rate (HR). Peak lactate was also assessed via finger prick capillary sample. Results. Fifty patients completed follow-up (23 Activity; 27 UC), 96% of whom satisfied peak CPET criteria (22 Activity; 26 UC). Compared to UC, there was a significant treatment benefit for Activity on V̇O2peak (net difference: 2.5 ml/kg/min [95% CI 0.3, 4.8], p=0.03) due to a 15% reduction in UC (-3.4 ml/kg/min [95% CI -4.9, -1.8], p<0.001) and no significant change in Activity (-0.9 ml/kg/min [95% CI -2.5, 0.8], p=0.31). Similarly, PPO declined less in Activity than UC (-11% vs. -24%; interaction, p=0.03), while peak HR and lactate reduced similarly in Activity and UC (-9 vs. -7 beats/min, p=0.75; -1.3 vs -2.2 mmol/L; p=0.22). Peak RER was unchanged in both groups. Conclusion. A multifaceted activity program targeting exercise and sedentary behaviour is effective in attenuating allo-SCT-induced declines in V̇O2peak. Whether these benefits on VO2peak translate to reduced cardiovascular morbidity and greater longevity warrants investigation.